Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, do...

por Iwanuk, Nayeli, Nolte, Ingo, Wall, Leona, Sehn, Maximiliane, Raue, Jonathan, Pilgram, Anna, Rumstedt, Katja, Bach, Jan-Peter
Publicado 2019

Effect of pimobendan on physical fitness, lactate and echocardiographic parameters in dogs with preclinical mitral valve disease without cardiomegaly

por Iwanuk, Nayeli, Wall, Leona, Nolte, Ingo, Raue, Jonathan, Rumstedt, Katja, Pilgram, Anna, Sehn, Maximiliane, Rohn, Karl, Bach, Jan-Peter
Publicado 2019

The effect of treatment with pimobendan in dogs with preclinical mitral valve disease – a placebo-controlled double-blinded crossover study

por Klein, Stephanie, Nolte, Ingo, Rumstedt, Katja, Sehn, Maximiliane, Raue, Jonathan Friedemann, Weiner, Franziska, Treese, Julia Sophie, Beyerbach, Martin, Bach, Jan-Peter
Publicado 2021

Evaluation of new and old biomarkers in dogs with degenerative mitral valve disease

por Klein, Stephanie, Nolte, Ingo, Granados-Soler, José Luis, Lietz, Philipp, Sehn, Maximiliane, Raue, Jonathan Friedemann, Rohn, Karl, Packeiser, Eva-Maria, Bach, Jan-Peter
Publicado 2022